DVA DAVITA INC
2026Q1 · CUSIP 23918K108 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
577
Δ holders QoQ
+47
Breadth percentile
Top 5%
Whale holders
237
Δ whales
+5
Inst. holding value
$9.5B
New positions
129
Closed positions
82
Price momentum (1Q)
+32.7%
Put / Call
14/13
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 5% | — | — |
| 2024Q3 | Top 6% | -9.5% | -12.0% |
| 2024Q2 | Top 13% | +2.7% | +3.1% |
| 2023Q4 | Top 15% | +14.4% | +24.5% |
| 2023Q3 | Top 4% | +29.8% | +48.8% |
| 2023Q2 | Top 6% | -11.7% | +14.9% |
| 2022Q1 | Top 9% | -9.3% | -29.0% |
| 2021Q2 | Top 15% | -19.6% | -13.6% |
Options Sentiment
Put holders
14
QoQ: 0
Call holders
13
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
21.8
EPS (TTM)
$10.71
EPS YoY
+6.3%
Revenue (TTM)
$13.8B
Revenue YoY
+6.7%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)